NIA
ABBV icon

NIA Impact Advisors’s AbbVie ABBV Stock Holding History

NIA Impact Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Sell
1,251
-546
-30% -$117K 0.13% 57
2026
Q1 		$391K Sell
1,797
-214
-11% -$47.5K 0.17% 75
2025
Q4 		$460K Buy
2,011
+355
+21% +$80.9K 0.15% 78
2025
Q3 		$383K Buy
1,656
+111
+7% +$22.6K 0.12% 83
2025
Q2 		$287K Sell
1,545
-245
-14% -$45.5K 0.1% 86
2025
Q1 		$375K Sell
1,790
-597
-25% -$116K 0.14% 83
2024
Q4 		$424K Buy
2,387
+177
+8% +$32.5K 0.14% 89
2024
Q3 		$436K Buy
2,210
+220
+11% +$41.1K 0.14% 83
2024
Q2 		$341K Buy
1,990
+490
+33% +$81.2K 0.12% 89
2024
Q1 		$273K Buy
+1,500
New +$259K 0.11% 85

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NIA Impact Advisors's ABBV Position: Q2 2026 in Review

NIA Impact Advisors reduced its AbbVie (ABBV) stake by 30% in Q2 2026, selling an estimated $117K and leaving 1,251 shares worth $315K. The position accounts for 0.13% of the portfolio, ranked #57.

NIA Impact Advisors first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $460K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NIA Impact Advisors held 1,251 shares of AbbVie worth $315K as of Q2 2026.
  • NIA Impact Advisors sold 546 AbbVie shares in Q2 2026, an estimated $117K.
  • AbbVie made up 0.13% of NIA Impact Advisors's portfolio in Q2 2026, its #57 holding.
  • NIA Impact Advisors first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • NIA Impact Advisors's AbbVie position peaked at $460K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.